OR WAIT null SECS
July 02, 2020
RNA is easier to manipulate than DNA but challenging to deliver to the right cells.
June 30, 2020
The site can now support customized product and bioprocess development and custom cell and gene therapy reagent manufacturing.
June 29, 2020
The companies are entering into a license agreement to provide CSL Behring with exclusive global rights to etranacogene dezaparvovec, uniQure’s investigational gene therapy for patients with hemophilia B.
June 22, 2020
The company will invest $75 million into its Canton, MA, facility to expand its viral vector, gene therapy, and contract development and manufacturing capabilities.
June 08, 2020
Previous investments set a foundation for later efficiency improvements.
June 04, 2020
The VIA Capsule from Cytiva is a liquid nitrogen-free cryogenic shipment system designed to transport cell therapies.
May 18, 2020
Ori Biotech is partnering with manufacturers and materials suppliers to develop an automated system for cell and gene therapy manufacturing.
May 15, 2020
Synthetic depth filters are a suitable option to provide a high-performance and scalable single-step clarification process.
May 13, 2020
The company will invest $180 million to construct a new 290,000-ft2 facility in Plainville, MA.
Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma entered into long-term development and manufacturing services agreements for the clinical and commercial supply of multiple bluebird bio therapies.